Does the media prefer COO or XRAY?

In the previous week, Cooper Companies had 3 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 21 mentions for Cooper Companies and 18 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 1.03 beat DENTSPLY SIRONA's score of 0.07 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 12 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive DENTSPLY SIRONA 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to XRAY or MMSI?

In the previous week, DENTSPLY SIRONA had 11 more articles in the media than Merit Medical Systems. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 7 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.24 beat DENTSPLY SIRONA's score of 0.07 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Merit Medical Systems 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to XRAY or NVST?

In the previous week, DENTSPLY SIRONA had 8 more articles in the media than Envista. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 10 mentions for Envista. Envista's average media sentiment score of 1.16 beat DENTSPLY SIRONA's score of 0.07 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Envista 6 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor XRAY or BLCO?

In the previous week, DENTSPLY SIRONA had 11 more articles in the media than Bausch + Lomb. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 7 mentions for Bausch + Lomb. Bausch + Lomb's average media sentiment score of 0.43 beat DENTSPLY SIRONA's score of 0.07 indicating that Bausch + Lomb is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Bausch + Lomb 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to XRAY or ICUI?

In the previous week, DENTSPLY SIRONA had 12 more articles in the media than ICU Medical. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 6 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.12 beat DENTSPLY SIRONA's score of 0.07 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral ICU Medical 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

DENTSPLY SIRONA (XRAY) Competitors

$11.43 +0.14 (+1.24%)

As of 04:00 PM Eastern

Compare

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

Should you buy DENTSPLY SIRONA stock or one of its competitors? DENTSPLY SIRONA's main competitors and comparable companies include Cooper Companies (COO), Merit Medical Systems (MMSI), Envista (NVST), Bausch + Lomb (BLCO), and ICU Medical (ICUI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does DENTSPLY SIRONA compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and DENTSPLY SIRONA (NASDAQ:XRAY) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

Cooper Companies has a net margin of 5.57% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
DENTSPLY SIRONA	-14.99%	20.84%	5.32%

Cooper Companies has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

Cooper Companies presently has a consensus target price of $81.64, indicating a potential upside of 15.58%. DENTSPLY SIRONA has a consensus target price of $13.54, indicating a potential upside of 18.45%. Given DENTSPLY SIRONA's higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cooper Companies has higher revenue and earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	3.37	$374.90M	$1.18	59.86
DENTSPLY SIRONA	$3.64B	0.63	-$598M	-$2.75	N/A

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Cooper Companies had 3 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 21 mentions for Cooper Companies and 18 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 1.03 beat DENTSPLY SIRONA's score of 0.07 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	12 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Cooper Companies beats DENTSPLY SIRONA on 13 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Merit Medical Systems?

DENTSPLY SIRONA (NASDAQ:XRAY) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

In the previous week, DENTSPLY SIRONA had 11 more articles in the media than Merit Medical Systems. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 7 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.24 beat DENTSPLY SIRONA's score of 0.07 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Merit Medical Systems	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

DENTSPLY SIRONA currently has a consensus target price of $13.54, indicating a potential upside of 18.45%. Merit Medical Systems has a consensus target price of $100.00, indicating a potential upside of 12.91%. Given DENTSPLY SIRONA's higher probable upside, research analysts clearly believe DENTSPLY SIRONA is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

Merit Medical Systems has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.64B	0.63	-$598M	-$2.75	N/A
Merit Medical Systems	$1.52B	3.49	$128.49M	$2.42	36.60

Merit Medical Systems has a net margin of 9.22% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Merit Medical Systems	9.22%	13.75%	8.10%

DENTSPLY SIRONA has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, indicating that its share price is 51% less volatile than the broader market.

Summary

Merit Medical Systems beats DENTSPLY SIRONA on 12 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Envista?

DENTSPLY SIRONA (NASDAQ:XRAY) and Envista (NYSE:NVST) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Envista has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.64B	0.63	-$598M	-$2.75	N/A
Envista	$2.72B	1.63	$47M	$0.58	47.47

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, DENTSPLY SIRONA had 8 more articles in the media than Envista. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 10 mentions for Envista. Envista's average media sentiment score of 1.16 beat DENTSPLY SIRONA's score of 0.07 indicating that Envista is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envista	6 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DENTSPLY SIRONA has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Envista has a net margin of 3.33% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Envista	3.33%	7.88%	4.33%

DENTSPLY SIRONA presently has a consensus target price of $13.54, suggesting a potential upside of 18.45%. Envista has a consensus target price of $29.71, suggesting a potential upside of 7.93%. Given DENTSPLY SIRONA's higher probable upside, equities analysts plainly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.56

Summary

Envista beats DENTSPLY SIRONA on 11 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Bausch + Lomb?

DENTSPLY SIRONA (NASDAQ:XRAY) and Bausch + Lomb (NYSE:BLCO) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

Bausch + Lomb has higher revenue and earnings than DENTSPLY SIRONA. Bausch + Lomb is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.64B	0.63	-$598M	-$2.75	N/A
Bausch + Lomb	$5.10B	1.27	-$360M	-$0.48	N/A

DENTSPLY SIRONA presently has a consensus price target of $13.54, indicating a potential upside of 18.45%. Bausch + Lomb has a consensus price target of $18.75, indicating a potential upside of 3.25%. Given DENTSPLY SIRONA's higher probable upside, equities analysts plainly believe DENTSPLY SIRONA is more favorable than Bausch + Lomb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bausch + Lomb	1 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.31

Bausch + Lomb has a net margin of -3.21% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Bausch + Lomb	-3.21%	4.14%	1.93%

DENTSPLY SIRONA has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 1.5% of Bausch + Lomb shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, DENTSPLY SIRONA had 11 more articles in the media than Bausch + Lomb. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 7 mentions for Bausch + Lomb. Bausch + Lomb's average media sentiment score of 0.43 beat DENTSPLY SIRONA's score of 0.07 indicating that Bausch + Lomb is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bausch + Lomb	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Bausch + Lomb beats DENTSPLY SIRONA on 9 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to ICU Medical?

DENTSPLY SIRONA (NASDAQ:XRAY) and ICU Medical (NASDAQ:ICUI) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

ICU Medical has a net margin of 1.39% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
ICU Medical	1.39%	7.91%	4.17%

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by insiders. Comparatively, 2.1% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

ICU Medical has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.64B	0.63	-$598M	-$2.75	N/A
ICU Medical	$2.16B	1.92	$730K	$1.18	140.92

DENTSPLY SIRONA has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market.

In the previous week, DENTSPLY SIRONA had 12 more articles in the media than ICU Medical. MarketBeat recorded 18 mentions for DENTSPLY SIRONA and 6 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.12 beat DENTSPLY SIRONA's score of 0.07 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
ICU Medical	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DENTSPLY SIRONA currently has a consensus target price of $13.54, suggesting a potential upside of 18.45%. ICU Medical has a consensus target price of $192.80, suggesting a potential upside of 15.94%. Given DENTSPLY SIRONA's higher probable upside, equities research analysts clearly believe DENTSPLY SIRONA is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89

Summary

ICU Medical beats DENTSPLY SIRONA on 11 of the 17 factors compared between the two stocks.

Get DENTSPLY SIRONA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XRAY vs. The Competition

Export

Metric	DENTSPLY SIRONA	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.28B	$5.70B	$7.24B	$12.90B
Dividend Yield	N/A	1.75%	2.53%	8.56%
P/E Ratio	-4.16	25.93	273.57	25.42
Price / Sales	0.63	84.17	675.05	123.41
Price / Cash	1.79	33.05	76.98	52.08
Price / Book	1.69	6.05	12.91	6.15
Net Income	-$598M	$150.03M	$3.47B	$349.01M
7 Day Performance	3.53%	-1.27%	-0.46%	-1.48%
1 Month Performance	-19.11%	3.27%	6.40%	2.46%
1 Year Performance	-17.83%	7.15%	24.88%	15.76%

DENTSPLY SIRONA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XRAY DENTSPLY SIRONA	4.4302 of 5 stars	$11.43 +1.2%	$13.54 +18.4%	-18.2%	$2.28B	$3.64B	N/A	14,000
COO Cooper Companies	3.9088 of 5 stars	$75.80 -0.6%	$81.64 +7.7%	+6.7%	$14.87B	$4.09B	64.24	15,000	Upcoming Earnings
MMSI Merit Medical Systems	3.9559 of 5 stars	$90.28 -0.6%	$100.00 +10.8%	-0.6%	$5.42B	$1.52B	37.31	7,500	Positive News
NVST Envista	3.3882 of 5 stars	$27.34 +0.5%	$29.31 +7.2%	+32.2%	$4.37B	$2.72B	47.15	12,000	Positive News Analyst Upgrade
BLCO Bausch + Lomb	2.8005 of 5 stars	$17.34 +0.6%	$18.75 +8.2%	+21.9%	$6.16B	$5.10B	N/A	13,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XRAY) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

How does DENTSPLY SIRONA compare to Cooper Companies?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Summary

How does DENTSPLY SIRONA compare to Envista?

Summary

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

How does DENTSPLY SIRONA compare to Cooper Companies?

Is COO or XRAY more profitable?

Which has more risk and volatility, COO or XRAY?

Do analysts recommend COO or XRAY?

Which has better earnings & valuation, COO or XRAY?

Do insiders and institutionals believe in COO or XRAY?

Does the media prefer COO or XRAY?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Does the media refer more to XRAY or MMSI?

Do insiders & institutionals hold more shares of XRAY or MMSI?

Do analysts rate XRAY or MMSI?

Which has higher earnings & valuation, XRAY or MMSI?

Is XRAY or MMSI more profitable?

Which has more volatility & risk, XRAY or MMSI?

Summary

How does DENTSPLY SIRONA compare to Envista?

Which has better earnings & valuation, XRAY or NVST?

Do institutionals and insiders have more ownership in XRAY or NVST?

Does the media refer more to XRAY or NVST?

Which has more risk & volatility, XRAY or NVST?

Is XRAY or NVST more profitable?

Do analysts prefer XRAY or NVST?

Summary

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Which has better valuation and earnings, XRAY or BLCO?

Do analysts recommend XRAY or BLCO?

Is XRAY or BLCO more profitable?

Which has more volatility and risk, XRAY or BLCO?

Do institutionals & insiders believe in XRAY or BLCO?

Does the media favor XRAY or BLCO?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Is XRAY or ICUI more profitable?

Do institutionals and insiders hold more shares of XRAY or ICUI?

Which has preferable valuation and earnings, XRAY or ICUI?

Which has more volatility & risk, XRAY or ICUI?

Does the media refer more to XRAY or ICUI?

Do analysts recommend XRAY or ICUI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools